Rebecca Olin
Professor · University of California (San Francisco) School of Medicine
Credentials: · · · · ·
History
- 2009–2012
Hospital
- 2003–2006
Research
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
New England Journal of Medicine · 2019 · 1,078 citations
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 359 citations
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2017 · 339 citations
17 papers
17 papers
17 papers
16 papers · 2 as a fellow
15 papers
15 papers
15 papers
14 papers
Clinical trials
- 2016–2032
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Site PI · Recruiting · Phase 2, Phase 3
Beat AML, LLC